171 related articles for article (PubMed ID: 21757619)
1. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.
Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Morishima Y; Kodera Y;
Blood; 2011 Sep; 118(11):3186-90. PubMed ID: 21757619
[TBL] [Abstract][Full Text] [Related]
2. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Kojima S; Matsuyama T; Kato S; Kigasawa H; Kobayashi R; Kikuta A; Sakamaki H; Ikuta K; Tsuchida M; Hoshi Y; Morishima Y; Kodera Y
Blood; 2002 Aug; 100(3):799-803. PubMed ID: 12130489
[TBL] [Abstract][Full Text] [Related]
3. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
[TBL] [Abstract][Full Text] [Related]
5. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
Varney MD; Lester S; McCluskey J; Gao X; Tait BD
Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
[TBL] [Abstract][Full Text] [Related]
6. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Martin PJ; Rowley SD; Anasetti C; Chauncey TR; Gooley T; Petersdorf EW; van Burik JA; Flowers ME; Storb R; Appelbaum FR; Hansen JA
Blood; 1999 Oct; 94(7):2192-9. PubMed ID: 10498588
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
9. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Lee SJ; Klein J; Haagenson M; Baxter-Lowe LA; Confer DL; Eapen M; Fernandez-Vina M; Flomenberg N; Horowitz M; Hurley CK; Noreen H; Oudshoorn M; Petersdorf E; Setterholm M; Spellman S; Weisdorf D; Williams TM; Anasetti C
Blood; 2007 Dec; 110(13):4576-83. PubMed ID: 17785583
[TBL] [Abstract][Full Text] [Related]
10. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
[TBL] [Abstract][Full Text] [Related]
11. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
12. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
[TBL] [Abstract][Full Text] [Related]
14. [A study of HLA-DPA1 and DPB1 matching status for unrelated donor-recipient pairs matched at allele level for HLA-A, -B, -C, -DRB1 and -DQB1 loci].
Zhen JX; Zou HY; Jin SZ; Gao SQ; Wang DM; He LM; Deng ZH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):697-700. PubMed ID: 24327150
[TBL] [Abstract][Full Text] [Related]
15. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
16. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
17. Definition of HLA-DQ as a transplantation antigen.
Petersdorf EW; Longton GM; Anasetti C; Mickelson EM; Smith AG; Martin PJ; Hansen JA
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15358-63. PubMed ID: 8986816
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
[TBL] [Abstract][Full Text] [Related]
19. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
20. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
Blood; 1993 Apr; 81(7):1923-32. PubMed ID: 8461476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
